BeStock  
Stocks › 3D Printing › DDD

3D Systems DDD

US equityMarket cap rank #37353D Printing
$1.35 −$0.13 (-8.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.44 +6.91%
Open$1.43
Prev close$1.48
Day range$1.34 – $1.56
Volume4.74M
Market cap$244.74M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership81.5%+5.17 pts vs. prior quarter
Institutions holding245-1 vs. prior quarter
Insider trades (recent)22 buys / 28 sellsNet selling
Short interest25.57% of floatDays to cover 19.5 · as of 30 Oct 2026
Short-sale volume share14.6%5-day average of daily volume

Short-sale volume as % of daily volume

8%14%19%24%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$1.81M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

+$1.2MSuper+$590.0KBig−$2.3MMid−$1.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.9% of shares outstanding.

Largest holders

  • BlackRock8.75%
  • State Street Global Advisors8.13%
  • Aigh Capital Management, LLC4.88%
  • Vanguard Capital Management, LLC4.20%
  • Two Sigma Investments, LP3.94%
  • The Bank of Nova Scotia3.15%
  • D. E. Shaw & Co., L.P.2.56%
  • Marshall Wace LLP2.36%

By investor type

  • Mutual Fund48.11%
  • Hedge Fund23.09%
  • Public Company5.73%
  • Individual/Insider3.42%
  • Insurance Company1.66%
  • Private Company1.65%
  • Family Office/Trust1.16%
  • Government Pension Fund0.08%

Reported short interest has fallen from 26.23% to 25.57% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Pinnacle Associates, Ltd. Mutual Fund 2026/Q3 +1,916,783 1.4%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +1,708,552 1.0%
UBS Asset Management Mutual Fund 2026/Q3 +1,671,993 1.8%
LPL Financial LLC Mutual Fund 2026/Q3 +1,508,546 1.4%
BlackRock Mutual Fund 2026/Q3 +955,788 8.7%
Aigh Capital Management, LLC Hedge Fund 2026/Q3 +853,428 4.9%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +294,899 1.6%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +277,568 0.8%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +1,038,899 1.7%
Aigh Capital Management, LLC Hedge Fund 2026/Q3 +7,271,000 4.4%
Needham Investment Management, LLC Mutual Fund 2026/Q3 +3,525,200 2.1%
Medina Value Partners, LLC Hedge Fund 2026/Q3 +3,279,375 2.0%
BlackRock Mutual Fund 2026/Q3 +2,752,009 8.2%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +2,682,326 1.7%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +1,899,587 1.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
16 Sep 2026 Jeffrey Graves Chief Executive Officer Open Market Disposition -42,686 $3.55 1,231,596
16 Sep 2026 Phyllis Nordstrom Executive VP, CFO & Chief Administrative Officer Open Market Disposition -30,000 $3.58 715,871
7 Sep 2026 Charles Hull Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus Sale to Issuer -4,943 $3.38 513,577
7 Sep 2026 Jeffrey Graves Chief Executive Officer Sale to Issuer -39,959 $3.38 1,274,282
7 Sep 2026 Phyllis Nordstrom Executive VP, CFO & Chief Administrative Officer Sale to Issuer -47,396 $3.38 745,871
7 Sep 2026 Andrew Wright Senior VP of General Counsel & Corporate Secretary Sale to Issuer -5,818 $3.38 136,963
7 Sep 2026 Reji Puthenveetil Executive VP of Additive Solutions & Chief Commercial Officer Sale to Issuer -15,984 $3.38 486,144
7 Sep 2026 Joseph Zuiker Executive Vice President of Engineering & Operations Sale to Issuer -6,689 $3.38 271,362
19 Aug 2026 Jeffrey Graves Chief Executive Officer Open Market Disposition -115,500 $3.26 1,314,241
13 May 2026 Jim Kever Independent Director Other Acquisition +45,731 – 560,650
13 May 2026 Thomas Erickson Independent Director Other Acquisition +45,731 – 395,178
13 May 2026 Kevin Moore Independent Director Other Acquisition +45,731 – 317,427
13 May 2026 Charles McClure Independent Chairperson Other Acquisition +45,731 – 227,848
13 May 2026 John Tracy Independent Director Other Acquisition +45,731 – 226,442
13 May 2026 Malissia Clinton Independent Director Other Acquisition +45,731 – 200,669
13 May 2026 Vasant Padmanabhan Independent Director Other Acquisition +45,731 – 192,915
13 May 2026 Claudia Drayton Independent Director Other Acquisition +45,731 – 174,369
13 Apr 2026 Charles Hull Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus Sale to Issuer -4,102 $1.98 518,520
13 Apr 2026 Jeffrey Graves Chief Executive Officer Sale to Issuer -30,500 $1.98 1,429,741
13 Apr 2026 Phyllis Nordstrom Executive VP, CFO & Chief Administrative Officer Sale to Issuer -1,626 $1.98 793,267

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 42,482,339 25.6% 19.5
15 Oct 2026 43,657,910 26.3% 15.3
30 Sep 2026 43,767,924 26.3% 17.2
15 Sep 2026 43,937,708 26.4% 21.3
31 Aug 2026 43,721,595 26.3% 22.7
14 Aug 2026 43,582,815 26.2% 8.2

Discussion

No comments yet — be the first to weigh in on DDD.

Sign in to join the discussion.

Scroll to Top